In the literature, Melo et al. reported a cell surface proteoglycan, glypican-1 (GPC1) which was specifically enriched in cancer cell-derived exosomes, to detect the early stage of pancreas cancer with high sensitivity and specificity [35]. This evidence concerns the gene GPC1 and pancreatic neoplasm.